ABOUT US

QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. Our products serve a wide range of applications, including cell and gene therapy. In this space, customers can find solutions for precise determination of plasmid quality, viral titer, vector copy number and robust contaminant testing. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. Together, we are making improvements in life possible.

FEATURED ARTICLES

  • Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.

  • Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.

  • Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.

  • Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

  • Gene therapy is transforming treatment for genetic disorders. With over 30 FDA-approved therapies, gain expert insight into how digital PCR enhances AAV vector precision, safety, and regulatory compliance in development.

  • Residual host cell DNA monitoring is vital in biologics manufacturing. Learn how digital PCR offers unmatched sensitivity and precision to ensure compliance with strict safety standards set by global regulatory agencies.

  • Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.

  • Explore how digital PCR technologies offer precise, reproducible AAV quantification to address qPCR limitations with streamlined workflows and dedicated CGT assays to support safe, consistent gene therapy development.

  • Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.

  • Ensure biopharmaceutical safety with a validated RT-dPCR workflow for mycoplasma detection. Learn how Mycoplasma Standard CFU Kits support compliance and robust contamination testing across diverse sample types.

CONTACT INFORMATION

QIAGEN

QIAGEN Strasse 1

Hilden, 40724

GERMANY

Contact: https://www.qiagen.com/us/contact-us

FEATURED WEBINARS